In the 12 months to Nov 19, 2026, on the open market: bought $135.4M of BRVE, ETRA, WWB and 4 more; sold $60.8M of ELVN, SION. Filed a median of 2 business days after the trade.
Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these
Insider purchases above the line: $135.4MInsider sales below: $60.8M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
WWBBought: WINDWARD BIO GROUP AG Nov 16, 20261,176,471 sharesfiled Nov 18, 20261,708,103 shares held indirectly after, as filedfiling$20.0M
ETRABought: Electra Therapeutics, Inc. Nov 10, 202622,700 sharesfiled Nov 10, 20262 transactionsfiling$192K
ETRABought: Electra Therapeutics, Inc. Nov 9, 202620,000 sharesfiled Nov 10, 20262 transactionsfiling$165K
ETRABought: Electra Therapeutics, Inc. Nov 6, 202649,416 sharesfiled Nov 10, 20262 transactionsfiling$388K
ETRABought: Electra Therapeutics, Inc. Nov 5, 2026156,091 sharesfiled Nov 5, 20262 transactionsfiling$1.1M
ETRABought: Electra Therapeutics, Inc. Nov 4, 202671,367 sharesfiled Nov 5, 20264 transactionsfiling$537K
ETRABought: Electra Therapeutics, Inc. Nov 3, 2026245,113 sharesfiled Nov 5, 20264 transactionsfiling$1.9M
ASPEBought: Aspen Neuroscience, Inc. Nov 2, 20261,000,000 sharesfiled Nov 4, 20263,589,132 shares held indirectly after, as filedfiling$15.0M
BLSMBought: BlossomHill Therapeutics, Inc. Aug 10, 2026625,000 sharesfiled Aug 12, 20262,714,279 shares held indirectly after, as filedfiling$10.0M
BRVEBought: Braveheart Bio, Inc. Aug 7, 20261,940,000 sharesfiled Aug 11, 20262 transactionsfiling$34.9M
SCTXBought: Scribe Therapeutics, Inc. Jul 27, 20261,000,000 sharesfiled Jul 29, 20261,348,825 shares held indirectly after, as filedfiling$15.0M
SIONSold: Sionna Therapeutics, Inc. Jul 7, 202685,918 sharesfiled Jul 9, 20262,469,959 shares held indirectly after, as filed10b5-1 planfiling$3.9M
SIONSold: Sionna Therapeutics, Inc. Jun 30, 2026115,844 sharesfiled Jul 2, 20262,555,877 shares held indirectly after, as filed10b5-1 planfiling$5.3M
ELVNSold: Enliven Therapeutics, Inc. Jun 22, 2026860,123 sharesfiled Jun 24, 20264 transactionsfiling$39.0M
ELVNSold: Enliven Therapeutics, Inc. Jun 15, 2026281,408 sharesfiled Jun 17, 20262 transactionsfiling$12.7M
Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.
Stakes filed (13D/13G)
Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Filings made under this filer's SEC CIK in the same 12 months, newest first; the figure is the percentage the filing states. Every recent 13D and 13G
Not counted above: entries this filer reported on Form 4 in the same 12 months that are not open-market purchases or sales. Each entry is one line of a filing.
WWB: shares withheld for tax or exercise price (code F), 1 entry, Nov 16, 2026
WWB: option exercise or conversion (code M), 1 entry, Nov 16, 2026
Code C
A conversion of a derivative security, such as preferred stock or units, into shares.
Code F
Shares paid to, or withheld by, the company to cover an exercise price or the tax due on an award.
Code M
An exercise or conversion of a derivative security received from the company, such as stock options.
Source: the same SEC Form 4 filings. The codes are the SEC's own transaction codes; the meanings above are a plain-words reading of the SEC's Form 4 instructions.